Research Progress and Prospects of Isocitrate Dehydrogenase Gene Mutation in Chondrosarcoma
Isocitrate dehydrogenase (IDH) is the more mutation-prone human metabolic gene. In the presence of nicotinamide adenine dinucleotide phosphate (NADPH), mutant IDH can bind to α-ketoglutaric acid (α-KG) and reduce it to 2-hydroxyglutaric acid (2-HG), participating in various bio...
Main Author: | ZHAO Jingjing, ZHANG Zhihong, ZHEN Junping |
---|---|
Format: | Article |
Language: | zho |
Published: |
Chinese General Practice Publishing House Co., Ltd
2024-04-01
|
Series: | Zhongguo quanke yixue |
Subjects: | |
Online Access: | https://www.chinagp.net/fileup/1007-9572/PDF/20230284.pdf |
Similar Items
-
Grade 2, 3 and Dedifferentiated Chondrosarcomas: A Comparative Study of Isocitrate Dehydrogenase-Mutant and Wild-Type Tumors with Implications for Prognosis and Therapy
by: Karen Schoedel, et al.
Published: (2024-01-01) -
Maffucci syndrome complicated by giant chondrosarcoma in the left ankle with an IDH1 R132C mutation: a case report
by: Haiyan Lv, et al.
Published: (2022-06-01) -
Research Progress of Isocitrate Dehydrogenase Gene Mutation Therapy
by: LIN Meijia, et al.
Published: (2023-03-01) -
Isocitrate Dehydrogenase Mutations in Myelodysplastic Syndromes and in Acute Myeloid Leukemias
by: Ugo Testa, et al.
Published: (2020-08-01) -
Advances in Immune Microenvironment and Immunotherapy of Isocitrate Dehydrogenase Mutated Glioma
by: Dongming Yan, et al.
Published: (2022-06-01)